View Older Stories View More Recent Stories

Feb 13, 2017 02:17PM Form SC 13G/A SYNERGY PHARMACEUTICALS, Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:16PM Form SC 13G NEWLINK GENETICS CORP Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:15PM Form SC 13G Lion Biotechnologies, Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:14PM Form SC 13G INOTEK PHARMACEUTICALS Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:12PM Form SC 13G/A IMMUNOMEDICS INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:11PM Form SC 13G/A IMMUNOGEN INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:10PM Form SC 13G/A GLAUKOS Corp Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:09PM Form SC 13G/A FLUIDIGM CORP Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:07PM Form SC 13G Cellectis S.A. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:57PM Form SC 13G/A Wright Medical Group Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:55PM Form SC 13G/A ProQR Therapeutics N.V. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:53PM Form SC 13G/A PUMA BIOTECHNOLOGY, INC. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:51PM Form SC 13G/A MAGELLAN HEALTH INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:51PM Form SC 13G/A Ophthotech Corp. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:49PM Form SC 13G/A IRONWOOD PHARMACEUTICALS Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:47PM Form SC 13G/A Insys Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:47PM Form SC 13G/A IMPAX LABORATORIES INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:44PM Form SC 13G/A INSMED Inc Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:42PM Form SC 13G/A INFINITY PHARMACEUTICALS Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:41PM Form SC 13G/A eHealth, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:39PM Form SC 13G/A DYNAVAX TECHNOLOGIES Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:38PM Form SC 13G/A Sierra Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:36PM Form SC 13G/A CONNECTURE INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:35PM Form SC 13G/A ARRAY BIOPHARMA INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:35PM Form SC 13G/A CERUS CORP Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:32PM Form SC 13G/A AFFYMETRIX INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:30PM Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: ORBIMED ADVISORS LLC
Feb 10, 2017 04:14PM venBio Comments on Immunomedics Partnership Announcement
Feb 7, 2017 04:56PM Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 6, 2017 06:58AM ISS Endorses Full Slate of venBio Nominees at Immunomedics
Feb 3, 2017 01:25PM Form SC 13G ObsEva SA Filed by: ORBIMED ADVISORS LLC
Feb 2, 2017 02:25PM OrbiMed Comments on Immunomedics Proxy Contest
Jan 27, 2017 01:10PM Form SC 13D/A Affimed N.V. Filed by: ORBIMED ADVISORS LLC
Jan 20, 2017 04:25PM Form 4 ViewRay, Inc. For: Jan 18 Filed by: ORBIMED ADVISORS LLC
Jan 20, 2017 04:20PM Form SC 13D/A ViewRay, Inc. Filed by: ORBIMED ADVISORS LLC
Jan 18, 2017 04:17PM ViewRay (VRAY) Raises $26.1 Million in Private Placement of Common Stock and Warrants
Jan 18, 2017 04:01PM ViewRay Raises $26.1 Million in Private Placement
Jan 17, 2017 08:38AM PlacementTracker Publishes 2016 Private Placement Market League Tables
Jan 12, 2017 11:12AM Form SC 13D/A Loxo Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Dec 30, 2016 04:22PM Form 3 Nabriva Therapeutics AG For: Dec 30 Filed by: ORBIMED ADVISORS LLC
Dec 12, 2016 12:00PM Sonendo® Closes $35 Million Equity Financing Round
Dec 12, 2016 09:00AM Treato Appoints Healthcare Industry Veteran Allen Kamer to its Board of Directors
Dec 8, 2016 05:10PM Form SC 13G/A SUNOVION CNS DEVELOPMENT Filed by: ORBIMED ADVISORS LLC
Dec 1, 2016 04:56PM Form SC 13D/A RESPONSE BIOMEDICAL CORP Filed by: ORBIMED ADVISORS LLC
Nov 29, 2016 12:42PM Response Biomedical Corp. Completes Going-Private Transaction
Nov 16, 2016 10:22AM Inspire Medical Systems Completes 1,000th Implant, Names Marilyn Carlson Nelson to the Board, and Completes Series F Financing
Nov 14, 2016 05:07PM Form 13F-HR ORBIMED ADVISORS LLC For: Sep 30
Nov 14, 2016 01:57PM Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 2, 2016 11:30AM FACIT Start-up Turnstone Biologics Closes USD $41M Financing
Oct 24, 2016 05:17PM Form SC 13D/A Ascendis Pharma A/S Filed by: ORBIMED ADVISORS LLC
View More Recent Stories View Older Stories